SMS Mobile Technology to Improve Early Childhood Vaccine Coverage in Guatemala (SMSVaxGuate)

September 24, 2019 updated by: University of Colorado, Denver
This project plans to learn more about whether sending text messages to parents on their mobile phones to remind them when their child is due for his or her next vaccination will improve children getting vaccinated on time.

Study Overview

Detailed Description

This project plans to learn more about whether sending text messages to parents on their mobile phones to remind them when their child is due for his or her next vaccination will improve children getting vaccinated on time. The vaccines that will be given are the same routine vaccinations registered in Guatemala and used by the Ministry of Health regardless of enrollment in the study.

Study Type

Interventional

Enrollment (Actual)

720

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Guatemala, Guatemala, 01015
        • University del Valle, Guatemala
    • Quetzaltenango
      • Coatepeque, Quetzaltenango, Guatemala
        • Fundacion para la Salud Integral de los Guatemaltecos CU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 6 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • First dose of primary vaccination series
  • Parents owning a mobile phone and able to decipher SMS messages
  • Consent form signed

Exclusion Criteria:

  • Moving away from the study site in the next 12 months
  • Ineligible for primary vaccination series by the MOH

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Short Message Service (SMS) group
Receiving SMS message reminders 1 week before scheduled vaccination
SMS messages will be delivered at 6, 4, and 2 days before the next scheduled date of the primary vaccines for the intervention group
Other Names:
  • text messages
Placebo Comparator: Usual care
Not receiving SMS messages
Health clinic nurse provides regular appointment in the vaccination card with no active reminders

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of vaccine primary series
Time Frame: 12 months of age
Completion of 2nd and 3rd dose of vaccines by 1 year of age
12 months of age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors associated with immunization delays
Time Frame: 12 months
Demographic, education and behavioral factors associated with days late for vaccination
12 months
Acceptability of SMS vaccine reminders
Time Frame: 12 months
Qualitative data from focus groups to evaluate acceptability of SMS program
12 months
Timeliness of immunization
Time Frame: 12 months
Days delayed from date for 2nd and 3rd dose of vaccination
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Edwin J Asturias, MD, University of Colorado, Denver
  • Principal Investigator: Gretchen Domek, MD, University of Colorado, Denver
  • Study Director: Ingrid L Contreras, MD, University del Valle, Guatemala

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

July 7, 2017

Study Completion (Actual)

July 10, 2017

Study Registration Dates

First Submitted

September 30, 2015

First Submitted That Met QC Criteria

September 30, 2015

First Posted (Estimate)

October 2, 2015

Study Record Updates

Last Update Posted (Actual)

September 26, 2019

Last Update Submitted That Met QC Criteria

September 24, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 14-2170
  • 1R21HD084115-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adherence to Vaccination Schedules

Clinical Trials on SMS message

3
Subscribe